News & Press Releases

Steven Shparber, Mintz Member, was quoted in a recent Utility Dive article analyzing the Federal Energy Regulatory Commission’s (FERC) rejection of Tri-State Generation and Transmission Association’s proposed large load tariff. The decision, which found that Tri-State’s proposal intruded on retail rate regulation—an area reserved for state jurisdiction—comes as FERC begins considering a U.S. Department of Energy proposal to streamline interconnections for data centers and other large loads.

Forbes featured insights from Of Counsel Michelle Capezza in an article about the distinction between risk capacity and risk tolerance in retirement planning. The article notes that while many retirement plan participants intuitively understand the concept of risk capacity, its nuances are not always reflected in 401(k) plans.

Steven Shparber, Mintz Member, was quoted in a recent Law360 article covering U.S. Department of Energy Secretary Chris Wright’s proposal urging the Federal Energy Regulatory Commission (FERC) to establish standardized procedures for interconnecting data centers and other large loads to the grid. The proposal argues that such interconnections fall squarely within FERC’s jurisdiction and are critical to supporting domestic manufacturing and AI innovation.

Business Law Today highlighted comments from Privacy & Cybersecurity Practice Co-chair Scott Lashway, who spoke on a panel at the American Bar Association Business Law Fall Meeting in September. Discussing the role of intellectual property in business transactions, the panel addressed important considerations for the various types of IP, distinguishing the less concrete “lowercase ip” from the more formalized “uppercase IP.”

Of Counsel Michelle Capezza shared comments with Fiduciary News about how 401k fiduciaries can implement risk capacity, including the importance of providing retirement plan participants with balanced educational materials.

Bloomberg Law quoted Member Joanne Hawana in a recent article about the FDA’s crackdown on potentially misleading drug advertisements following its investigation into the use of social media influencers to promote certain drugs. Attorneys and the telehealth companies they counsel explain in the article that clarity from the FDA is needed on who is responsible for influencer ad messaging, particularly when promoting compounded drugs.